Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,031 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Interferon-inducible cholesterol-25-hydroxylase restricts hepatitis C virus replication through blockage of membranous web formation.
Anggakusuma, Romero-Brey I, Berger C, Colpitts CC, Boldanova T, Engelmann M, Todt D, Perin PM, Behrendt P, Vondran FW, Xu S, Goffinet C, Schang LM, Heim MH, Bartenschlager R, Pietschmann T, Steinmann E. Anggakusuma, et al. Among authors: berger c. Hepatology. 2015 Sep;62(3):702-14. doi: 10.1002/hep.27913. Epub 2015 Jul 28. Hepatology. 2015. PMID: 25999047
Soraphen A: A broad-spectrum antiviral natural product with potent anti-hepatitis C virus activity.
Koutsoudakis G, Romero-Brey I, Berger C, Pérez-Vilaró G, Monteiro Perin P, Vondran FW, Kalesse M, Harmrolfs K, Müller R, Martinez JP, Pietschmann T, Bartenschlager R, Brönstrup M, Meyerhans A, Díez J. Koutsoudakis G, et al. Among authors: berger c. J Hepatol. 2015 Oct;63(4):813-21. doi: 10.1016/j.jhep.2015.06.002. Epub 2015 Jun 10. J Hepatol. 2015. PMID: 26070407
DEB025 (Alisporivir) inhibits hepatitis C virus replication by preventing a cyclophilin A induced cis-trans isomerisation in domain II of NS5A.
Coelmont L, Hanoulle X, Chatterji U, Berger C, Snoeck J, Bobardt M, Lim P, Vliegen I, Paeshuyse J, Vuagniaux G, Vandamme AM, Bartenschlager R, Gallay P, Lippens G, Neyts J. Coelmont L, et al. Among authors: berger c. PLoS One. 2010 Oct 27;5(10):e13687. doi: 10.1371/journal.pone.0013687. PLoS One. 2010. PMID: 21060866 Free PMC article.
ORPHEE: A Real-World Study on rIX-FP Prophylaxis Use in Adolescent/Adult Patients With Hemophilia B.
Volot F, Castet S, Fournel A, Frotscher B, Gillet B, Desprez D, Tardy B, Rauch A, Chamouni P, Biron-Andreani C, Valentin JB, Harroche A, Dargaud Y, Petesch BP, d'Oiron R, Berger C, Reynes C, Lauvray T, de Raucourt E, Hassoun A, Lebreton A, Cussac V, Catovic H, Martin C, Guillet B. Volot F, et al. Among authors: berger c. Eur J Haematol. 2024 Dec 5. doi: 10.1111/ejh.14357. Online ahead of print. Eur J Haematol. 2024. PMID: 39638755
Risk Factors, Treatments, and Outcomes of Adults Aged <55 Years With Acute Ischemic Stroke With Undetermined Versus Determined Pathogenesis: A Nationwide Swiss Cohort Study.
Dittrich TD, Schneider T, Katan M, Luft AR, Mono ML, Bolognese M, Nedeltchev K, Kahles T, Arnold M, Heldner M, Michel P, Carrera E, Rodic B, Cereda CW, Peters N, Bonati LH, Renaud S, Humm AM, Medlin F, Albert S, Sturzenegger R, Tarnutzer AA, Siebel P, Baumgärtner M, Berger C, Mordasini P, Vehoff J, De Marchis GM; Swiss Stroke Registry Investigators. Dittrich TD, et al. Among authors: berger c. J Am Heart Assoc. 2024 Dec 3;13(23):e036761. doi: 10.1161/JAHA.124.036761. Epub 2024 Nov 27. J Am Heart Assoc. 2024. PMID: 39604021 Free article.
2,031 results